Warner pharmaceutical: drugs pass the consistency evaluation of quality and efficacy of generic drugs
Warner pharmaceutical announced that the company has received the notice of approval for supplementary drug application for mycophenolate mofetil capsules approved and issued by the State Drug Administration. The drug mycophenolate mofetil capsule was evaluated by the consistency of quality and efficacy of generic drugs. The application of mycophenolate mofetil capsule together with corticosteroids, cyclosporine or tacrolimus is suitable for the treatment of patients receiving allogeneic kidney transplantation and liver transplantation, the prevention of organ rejection, and the induction and maintenance treatment of patients with type III-V adult lupus nephritis.
This text is a result of machine translation.
Related companies：
Briefing May 11, 2022 01:15 PM
· Technology
Photovoltaic sector continues to be active
Briefing May 10, 2022 06:30 PM
· Technology
Boschke: the consortium pre won the 168 million yuan EPC project
In-depth
Technology
DeepSeek | China's AI Global Breakthrough and Ecosystem Restructuring
Mar 19, 2025 01:18 PM
Briefing Apr 28, 2022 08:55 AM
CITIC Securities: the auction price of lithium concentrate rose sharply, and the lithium plate rebounded or advanced
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Mar 10, 2022 12:48 PM
· Consumer Staples
Half day net inflow of main funds into photovoltaic and lithium batteries, selling small metals, etc
See more
Read next
Insight
In-depth
Insight
In-depth
